We are live on ! Find out more
MCIM

Meadow Creek Investment Management Portfolio holdings

AUM $5.09B
1-Year Est. Return 5.82%
This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
+5.82%
3 Year Est. Return
+54.91%
5 Year Est. Return
10 Year Est. Return
AUM
$5.03B
AUM Growth
+$118M
Cap. Flow
-$50.5M
Cap. Flow %
-1%
Top 10 Hldgs %
23.21%
Holding
1,391
New
49
Increased
502
Reduced
319
Closed
40

Top Buys

Rank Stock Value
1
WAB icon
Wabtec
WAB
+$19.8M
2
LYB icon
LyondellBasell Industries
LYB
+$11.7M
3
MSFT icon
Microsoft
MSFT
+$11.5M
4
CMCSA icon
Comcast
CMCSA
+$11M
5
DAL icon
Delta Air Lines
DAL
+$9.78M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$23.8M
2
CELG
Celgene Corp
CELG
+$22.9M
3
INTC icon
Intel
INTC
+$15.9M
4
PYPL icon
PayPal
PYPL
+$9.32M
5
NKE icon
Nike
NKE
+$9.14M

Sector Composition

Rank Sector Weight
1 Technology 18.56%
2 Financials 15.29%
3 Healthcare 13.26%
4 Consumer Discretionary 12.8%
5 Communication Services 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRI icon
1226
Thomson Reuters
TRI
$46B
$93K ﹤0.01%
1,427
+212
+17% +$14K
ADEA icon
1227
Adeia
ADEA
$3.14B
$91K ﹤0.01%
16,692
ATRA icon
1228
Atara Biotherapeutics
ATRA
$77.7M
$90K ﹤0.01%
180
-56
-24% -$39.5K
TNC icon
1229
Tennant Co
TNC
$1.17B
$89K ﹤0.01%
1,456
SMAR
1230
DELISTED
Smartsheet Inc.
SMAR
$89K ﹤0.01%
1,840
+800
+77% +$34K
EXTN
1231
DELISTED
Exterran Corporation
EXTN
$89K ﹤0.01%
6,272
LDL
1232
DELISTED
Lydall, Inc.
LDL
$89K ﹤0.01%
4,396
+616
+16% +$13.4K
ACOR
1233
DELISTED
Acorda Therapeutics
ACOR
$87K ﹤0.01%
95
+22
+30% +$27K
BGG
1234
DELISTED
Briggs & Stratton Corp.
BGG
$87K ﹤0.01%
8,456
+1,064
+14% +$12K
BWXT icon
1235
BWX Technologies
BWXT
$15.6B
$86K ﹤0.01%
+1,652
New +$82.5K
CCRN
1236
DELISTED
Cross Country Healthcare
CCRN
$86K ﹤0.01%
9,180
GPRE icon
1237
Green Plains
GPRE
$1.09B
$86K ﹤0.01%
7,964
XYZ
1238
Block Inc
XYZ
$50.1B
$85K ﹤0.01%
1,176
-3,668
-76% -$256K
TIVO
1239
DELISTED
Tivo Inc
TIVO
$85K ﹤0.01%
11,584
TDAY
1240
USA Today Co
TDAY
$1B
$84K ﹤0.01%
8,866
KIDS icon
1241
OrthoPediatrics
KIDS
$650M
$84K ﹤0.01%
2,160
+1,200
+125% +$48.4K
CYTK icon
1242
Cytokinetics
CYTK
$10.3B
$83K ﹤0.01%
7,344
NX icon
1243
Quanex
NX
$982M
$82K ﹤0.01%
4,356
CVE icon
1244
Cenovus Energy
CVE
$56.5B
$81K ﹤0.01%
9,520
+1,652
+21% +$14.9K
GEOS icon
1245
Geospace Technologies
GEOS
$65.6M
$81K ﹤0.01%
5,372
NLY icon
1246
Annaly Capital Management
NLY
$17.6B
$81K ﹤0.01%
2,224
-14,636
-87% -$558K
TVTY
1247
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$81K ﹤0.01%
4,912
+912
+23% +$17.6K
SPTN
1248
DELISTED
SpartanNash
SPTN
$80K ﹤0.01%
6,864
+858
+14% +$12.2K
NTUS
1249
DELISTED
Natus Medical Inc
NTUS
$80K ﹤0.01%
3,104
VRS
1250
DELISTED
Verso Corporation
VRS
$80K ﹤0.01%
4,216

Similar funds

Meadow Creek Investment Management's Q2 2019 Portfolio in Review

As of Q2 2019, Meadow Creek Investment Management held 1,391 positions worth $5.03B, up 2.4% from $4.91B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Meadow Creek Investment Management's Q2 2019 filing shows 49 new, 502 increased, 319 reduced and 40 closed positions. Its largest new stake was L3Harris: 39,592 shares worth $7.49M. The largest sale was Linde, an estimated $23.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Meadow Creek Investment Management's largest Q2 2019 buy was L3Harris: 39,592 shares worth $7.49M.
  • Meadow Creek Investment Management added most to Wabtec in Q2 2019, an estimated $19.8M increase.
  • Meadow Creek Investment Management's biggest Q2 2019 reduction was Linde, cutting an estimated $23.8M.
  • Meadow Creek Investment Management fully exited Anadarko Petroleum in Q2 2019, selling an estimated $2.63M.
  • Meadow Creek Investment Management's ten largest holdings make up 23% of its $5.03B portfolio in Q2 2019.
  • Meadow Creek Investment Management opened 49 new positions and closed 40 in Q2 2019.
  • Meadow Creek Investment Management's portfolio value rose 2.4% quarter-over-quarter to $5.03B.

Based on Meadow Creek Investment Management's 13F filing for Q2 2019, filed 13 Aug 2019.